Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: Descriptive study results

Annals of Tropical Medicine and Public Health

Volumn 5, Issue 2, 2012, Pages 103-110

  Njomo, Doris W ^a,b   Amuyunzu Nyamongo, M ^c   Mukoko, Dunstan A ^d   Magambo, Japheth K ^b   Njenga, Sammy M ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^c African Institute for Health and Development   (Kenya)

^d Ministry of Public Health and Sanitation   (Kenya)

Author keywords

Albendazole; Compliance; Diethylcarbamazine; Lymphatic filariasis; Mass treatment

Indexed keywords

ADULT; AGED; ARTICLE; CHRISTIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; FEMALE; HUMAN; KENYA; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; MOSLEM; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RELIGION; RETROSPECTIVE STUDY; SOCIOECONOMICS;

EID: 84861307093     PISSN: 17556783     EISSN: 09746005     Source Type: Journal    
DOI: 10.4103/1755-6783.95962     Document Type: Article

References (28)

1. WHO. World Health Report 1995. Geneva: World Health Organization; 1995. p. 118.
2. Lymphatic filariasis: Progress of disability prevention activities. Wkly Epidemiol Rec 2004;79:417-24.
3. Bockarie M, Molyneux D. The end of lymphatic filariasis? BMJ 2009;338:b1686.
4. Recommendations of the International Task Force for Disease Eradication. MMWR Recomm Rep 1993;42:1-38.
5. Ottesen EA, Hooper PJ, Bradley M, Biswass G. The global programme to eliminate lymphatic filariasis: Health impact after 8 years. PLoS Negl Trop Dis 2008;2:e317.
6. Lammie P, Milner T, and Houston R. Unfulfilled potential, using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis. Bull World Health Organ 2007;85:545-9. (Pubitemid 47041633)
7. Micheal E, Malecela-Lazaro MN, Simonsen PE, Pederson EM, Barker G, Kumar A, et al. Mathematical modeling and the control of lymphatic filariasis. Lancet Infect Dis 2004;4:223-34. (Pubitemid 38407305)
8. Remme JH. The African programme for onchocerciasis control: Preparing to launch. Parasitol Today 1995;11:403-6.
9. WHO. Global Programme to eliminate lymphatic filariasis: Progress report on mass drug administration. Wkly Epidemiol Rec 2008;83: 333-41.
10. Babu BV, Kar SK. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 2004;9:702-9. (Pubitemid 38833335)
11. Ministry of Finance and Planning, Republic of Kenya. Population and housing census, Population distribution by administrative areas and urban centers. Central Bureau of Statistics 2001;11.
12. Ministry of Health, Republic of Kenya Annual Health Report Malindi District. Annual Operation Plan 1. 2006; p. 1-38.
13. Mukoko DA, Pedersen EM, Masese NN, Estambale BB, Ouma JH. Bancroftian filariasis in 12 villages in Kwale district, Coast province, Kenya-variation in clinical and parasitological patterns. Ann Trop Med Parasitol 2004;98:801-15. (Pubitemid 40013187)
14. Njenga SM, Muita M, Kirigi G, Mbugua J, Mitsui Y, Fujimaki Y, et al. Bancroftian filariasis in Kwale district, Kenya. East Afr Med J 2000;77:245-9. (Pubitemid 33209335)
15. Njenga SM, Wamae CN, Njomo DW, Mwandawiro CS, Molyneux DH. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochrmatographic test in Malindi, Kenya. Trans R Soc Trop Med Hyg 2008;102:1017-24.
16. Khan ME, Anker M, Patel BC, Barge S, Sadhwani H, Kohle R. The use of focus groups in social and behavioral research: Some methodological issues. World Health Stat Q 1991;44:145-9.
17. Weerasooriya MV, Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, Vidanapathirana KK, et al. Social mobilization, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic in Sri Lanka. Filaria J 2007;6:11.
18. Koenig HG. Collective Amnesia: The Absence of Religious Faith and Spirituality in Health Communication Research and Practice. Health Commun 2001;16:1-5.
19. Nandha B, Sadanandane C, Jambulingam P, Das P. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience. Filaria J 2007;6:7.
20. Yirga D, Deribe K, Woldemicheal K, Wendafrash M, Kassahun W. Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia. Parasit Vectors 2010;3:48.
21. Mathieu E, Direny AN, de Rochars MB, Streit TG, Adiss DG, Lammie PJ. Participation in three consecutive mass drug administrations in Leogane, Haiti. Trop Med Int Health 2006;11:862-8. (Pubitemid 43846446)
22. Rajendran R, Sunish IP, Munirathinam A, Ashok Kumar V, Tyagi BK. Role of community empowerment in the elimination of lymphatic filariasis in south India. Trop Biomed 2010;27:68-78.
23. Amuyuzu M. Community perceptions regarding chronic filarial swellings: A case study of the Duruma of Coastal Kenya. East Afr Med J 1997;74:411-5.
24. Nuwaha F, Okware J, Ndyomugyenyi R. Predictors of compliance with community-directed ivermectin treatment in Uganda: Quantitative results. Trop Med Int Health 2005;10:659-67. (Pubitemid 40933939)
25. Mathieu E, Lammie PJ, Raddy J, Beach MJ, Streit T, Wendt J, Adiss DG. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Ann Trop Med Parasitol 2004;98:703-14. (Pubitemid 39390074)
26. WHO. Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis. World Health Organization. WHO/CDSA/CPE/CEE/2000; 15.
27. March HN, Laigret J, Kessel JF, Bambridge B. Reduction in the prevalence of clinical filariasis in Tahiti following adoption of a control program. Am J Trop Med Hyg 1960;9:180-4.
28. Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, et al. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors 2009;2:39.